5-lipoxygenase metabolites inhibit bone formation in vitro

Endocrinology

Volumn 139, Issue 7, 1998, Pages 3178-3184

  Traianedes, Kathy ^a   Dallas, Mark R ^a   Garrett, I Ross ^a   Mundy, Gregory R ^a   Bonewald, Lynda F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ALKALINE PHOSPHATASE; ARACHIDONATE 5 LIPOXYGENASE; BONE MORPHOGENETIC PROTEIN; DEXAMETHASONE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE D4; PEPTIDOLEUKOTRIENE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BONE CELL; BONE MINERALIZATION; CALVARIA; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; IN VITRO STUDY; METABOLITE; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RAT;

EID: 0031731091     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.7.6115     Document Type: Article

References (37)

1. Sigal E 1991 The molecular biology of mammalian arachidonic acid metabolism. Am J Physiol 260:L13-L28
2. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG 1995 The role of prostaglandins in the regulation of bone metabolism. Clin Orthop 313:36-46
3. Klein DC, Raisz LG 1970 Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 86:1436-1440
4. 2 in infants with cyanotic congenital heart disease. J Pediatr 97:834-836
5. Norrdin RW, Jee WS, High WB 1990 The role of prostaglandins in bone in vivo. Prostaglandins Leukot Essent Fatty Acids 41:139-149
6. 2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcif Tissue Int 55:451-457
7. Gallwitz WE, Mundy GR, Lee CH, Qiao M, Roodman GD, Raftery M, Gaskell SJ, Bonewald LF 1993 5-lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem 268:10087-10094
8. Garcia C, Qiao M, Chen D, Kirchen M, Gallwitz W, Mundy GR, Bonewald LF 1996 Effects of synthetic peptido-leukotrienes on bone resorption in vitro. J Bone Miner Res 11:521-529
9. 4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 11:1619-1627
10. Bonewald LF, Flynn M, Qiao M, Dallas MR, Mundy GR, Boyce BF, Mice lacking 5-lipoxygenase have increased cortical bone thickness. Program of the 10th International Conference on Prostaglandins and Related Compounds, Vienna, Austria, 1996, p 50 (Abstract)
11. Bonewald LF, Flynn M, Qiao M, Dallas MR, Mundy GR, Boyce BF 1997 Mice lacking 5-lipoxygenase have increased cortical bone thickness. Adv Exp Med Biol 433:299-302
12. Bonewald LF, Rosser J, Dallas M, Storey B, Mundy GR, Boyce BF, Mice which lack the functional gene for 5-lipoxygenase lose significantly less bone than normal mice after ovariectomy. Program of the 19th Annual Meeting of the American Society of Bone and Mineral Research, Cincinnati, Ohio, 1997 (Abstract 37)
13. Nicolella DP, Nicholls AE, Bonewald LF, Lankford J, 1997 Mechanical properties of bone from mice lacking 5-lipoxygenase differ significantly from normal mice. Program of the 19th Annual Meeting of the American Society of Bone and Mineral Research, Cincinnati, Ohio, 1997, p 223 (Abstract)
14. Bellows CG, Aubin JE, Heersche JNM, Antosz ME 1986 Mineralized bone nodules formed in vitro from enzymatically released rat calvarial cell populations. Calcif Tissue Int 38:143-154
15. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR 1994 Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein-2, osteocalcin, osteopontin, alkaline phosphatase and type I collagen mRNA in long-term cultures of fetal rat calvarial cell osteoblasts. J Bone Miner Res 9:855-863
16. Harris SE, Sabatini M, Harris MA, Feng J, Wozney J, Mundy GR 1994 Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells. J Bone Miner Res 9:389-394
17. Traianedes K, Ng KW, Martin TJ, Findlay DM 1993 Cell substratum modulates responses of preosteoblasts to retinoic acid. J Cell Physiol 157:243-252
18. Bonewald LF, Wakefield L, Oreffo ROC, Escobedo A, Twardzik DR, Mundy GR 1991 Latent forms of transforming growth factor-β (TGFβ) derived from bone cultures: identification of a naturally occurring 100-kDa complex with similarity to recombinant latent TGFβ. Mol Endocrinol 5:741-751
19. Gowen M, Mundy GR 1986 Actions of recombinant interleukin 1, interleukin 2, and Interferon gamma on bone resorption in vitro. J Immunol 136:2478-2482
20. Meghji S, Sandy JR, Scutt AM, Harvey W, Harris M 1988 Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid. Prostaglandins 36:139-149
21. Canalis E 1996 Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
22. Lukert BP, Raisz LG 1990 Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364
23. Ren W, Dziak R 1993 Effects of leukotrienes on osteoblastic cell proliferation. Calcif Tissue Int 49:197-201
24. 4 increases intracellular calcium concentration and phosphoinositide metabolism in mouse osteoblasts via cyclic adenosine 3′, 5′-monophosphate-independent pathways. Endocrinology 129:582-590
25. Collins JL, Daniel JW, Cederquist R, Simmelink JW, Enlow DH, Stimulation of bone development by mechanical stress, and inhibition of leukotriene biosynthesis. Program of the 65th General Session, International Association for Dental Research Annual Session, American Association for Dental Research, Chicago, 1987, p 328
26. Henderson WR 1994 The role of leukotrienes in inflammation. Ann Intern Med 121:684-697
27. Pfeilschifter J, Wüster C, Vogel M, Enderes B, Ziegler R, Minne HW 1987 Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation. Calcif Tissue Int 41:321-325
28. Krempian B, Vukievic S, Vogel M, Stavljeni A, Büchele R 1988 Cellular basis of inflammation-induced osteopenia in growing rats. J Bone Miner Res 3:573-582
29. Compston JE, Vedi S, Croucher PI, Garrahan NJ, O'Sullivan MM 1994 Bone turnover in non-steroid treated rheumatoid arthritis. Ann Rheum Dis 53:163-166
30. Tyrrell JB 1995 Glucocorticoid therapy. In: Felig P, Baxter JD, Frohman LA (eds) Metabolism and Endocrinology. McGraw-Hill, New York, pp 855-882
31. Adinott AD, Hollister JR 1983 Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265-268
32. Peretz A, Praet J-P, Bosson D, Rosenberg S, Bourdoux P 1989 Serum osteocalcin in the assessment of corticosteroid-induced osteoporosis. Effect of long and short-term corticosteroid treatment. J Rheumatol 16:363-367
33. Manso G, Baker AJ, Taylor IK, Fuller RW 1992 In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. Eur Respir J 5:712-716
34. Riddick CA, Ring WL, Baker JR, Hodulik CR, Bigby TD 1997 Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. FEBS Lett 246:112-118
35. McMillan RM, Walker ERH 1992 Designing therapeutically effective 5-lipoxygenase inhibitors. Trends Pharmacol Sci 13:323-330
36. Ford-Hutchinson AW 1993 Leukotriene antagonists and inhibitors as modulators of Ig-E-mediated reactions. Springer Semin Immunopathol 15:37-50
37. Brooks CDW, Summers JB 1996 Modulators of leukotriene biosynthesis and receptor activation. J Med Chem 39:2630-2654